John Jay Treanor, M.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 689
Rochester, New York 14642

Office: 585 275-5871

Fax: 585 442-9328

Current Appointments

Education
MD Medicine Univ Rochester Sch Med/Dent 1979
BA Biology Canisius College 1975
Post-Doctoral Training & Residency
1979-1980 Medical Intern University of Vermont Burlington, Vermont
1980-1982 Medical Resident University of Vermont Burlington, Vermont
1982-1985 Fellow in Infectious Diseases University of Rochester Rochester, N.Y.
1985-1987 Senior Instructor Infectious Disease Unit University of Rochester Rochester, N.Y.
1987-1989 Senior Staff Fellow Laboratory of Infectious Disease National Institutes of Health Bethesda, Md.
Recent Journal Articles
Showing the 5 most recent journal articles. (103 available)
Zangwill KM; Treanor JJ; Campbell JD; Noah DL; Ryea J. "Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans." The Journal of infectious diseases. 2008; 197(4):580-3.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J. "Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines." Pediatrics. 2008; 121(2):e208-14.
Cohen S; Alper CM; Doyle WJ; Adler N; Treanor JJ; Turner RB. "Objective and subjective socioeconomic status and susceptibility to the common cold." Health psychology : official journal of the Division of Health Psychology, American Psychological Association. 2008; 27(2):268-74.
Talbot HK; Keitel W; Cate TR; Treanor J; Campbell J; Brady RC; Graham I; Dekker CL; Ho D; Winokur P; Walter E; Bennet J; Formica N; Hartel G; Skeljo M; Edwards KM. "Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine." Vaccine. 2008; 26(32):4057-61. Epub 2008 Jun 02.
Goji NA; Nolan C; Hill H; Wolff M; Noah DL; Williams TB; Rowe T; Treanor JJ. "Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant." The Journal of infectious diseases. 2008; 198(5):635-41.